Infliximab Concept

subject area of

• A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease  Academic Article
• A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease  Academic Article
• Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis  Academic Article
• American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis  Academic Article
• Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies  Academic Article
• Anti-TNFα therapy in immune-mediated subfertility: State of the art  Academic Article
• Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis  Academic Article
• Austrian infliximab experience in Crohn's disease  Academic Article
• Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis  Academic Article
• Biologic survival.  Academic Article
• C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I  Academic Article
• Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease  Academic Article
• Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease  Academic Article
• Change in Erythrocyte Mean Corpuscular Volume During Combination Therapy with Azathioprine and Infliximab Is Associated with Mucosal Healing  Academic Article
• Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial  Academic Article
• Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab  Academic Article
• Combination Therapy With Methotrexate in Inflammatory Bowel Disease: Time to COMMIT?  Academic Article
• Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs  Academic Article
• Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis  Academic Article
• Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?  Academic Article
• Drug monitoring of biologics in inflammatory bowel disease  Academic Article
• Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis  Academic Article
• Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis  Academic Article
• Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials  Academic Article
• Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab  Academic Article
• Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents  Academic Article
• Factors Associated With Short- and Long-Term Outcomes of Therapy for Crohn’s Disease  Academic Article
• Factors associated with changes in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from a case management survey  Academic Article
• Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn’s Disease Treated With Infliximab [Remicade®] or Conventional Therapy  Academic Article
• Improvement of Lumbar Bone Mass after Infliximab Therapy in Crohn’s Disease Patients  Academic Article
• Incidence and Management of Infusion Reactions to Infliximab in a Prospective Real-world Community Registry  Academic Article
• Infliximab  Academic Article
• Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection  Academic Article
• Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis  Academic Article
• Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.  Academic Article
• Infliximab in der Therapie der Colitis ulcerosa  Academic Article
• Infliximab in der Therapie des Morbus Crohn - ein praktischer Leitfaden: aktualisierter ÖGGH-Konsensus der Arbeitsgruppe Chronisch-entzündliche Darmerkrankungen der ÖGGH  Academic Article
• Infliximab in the Treatment of Crohn's Disease - a Practical Approach  Academic Article
• Infliximab or Cyclosporine as Rescue Therapy in Hospitalized Patients with Steroid-Refractory Ulcerative Colitis: A Retrospective Observational Study  Academic Article
• Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease  Academic Article
• Infliximab-Induced Psoriasis and Psoriasiform Skin Lesions in Pediatric Crohn Disease and a Potential Association With IL-23 Receptor Polymorphisms  Academic Article
• Letter: comparative safety and efficacy of infliximab vs. adalimumab in Crohn's disease - should one consider disease location? Authors’ reply  Academic Article
• Lewis-Sumner syndrome associated with infliximab therapy in rheumatoid arthritis  Academic Article
• Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies  Academic Article
• Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease  Academic Article
• Nail Psoriasis and Biologics  Academic Article
• Occurrence of Plantar Pustular Psoriasis during Treatment with Infliximab  Academic Article
• Patient outcomes after anti TNF-α drugs for Crohn’s disease  Academic Article
• Practical Understanding of Mean Percent Psoriasis Area and Severity Index Reduction for Biologics  Academic Article
• Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONICpost hocanalysis  Academic Article
• Recommendations for the treatment of ulcerative colitis with infliximab: A gastroenterology expert group consensus  Academic Article
• Refractory Primary Central Nervous System Vasculitis of Childhood: Successful Treatment with Infliximab  Academic Article
• Resource utilization during pediatric to adult transfer of care in IBD  Academic Article
• Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis  Academic Article
• Results of the 2nd scientific workshop of the ECCO (IV): Therapeutic strategies to enhance intestinal healing in inflammatory bowel disease  Academic Article
• Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis  Academic Article
• Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease  Academic Article
• Review article: causative factors and the clinical management of patients with Crohn’s disease who lose response to anti-TNF-α therapy  Academic Article
• Review article: dose optimisation of infliximab for acute severe ulcerative colitis  Academic Article
• Review article: infliximab for Crohn’s disease treatment - shifting therapeutic strategies after 10 years of clinical experience  Academic Article
• Soluble Biomarkers Associated with Response to Treatment with Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis  Academic Article
• Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids  Academic Article
• The Effects of Infliximab Therapy on Health-Related Quality of Life in Ulcerative Colitis Patients  Academic Article
• The Effects of a Monoclonal Antibody Directed against Tumor Necrosis Factor-α in Asthma  Academic Article
• The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohnʼs and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response?  Academic Article
• The Safety of Infliximab Infusions in the Community Setting  Academic Article
• The efficacy and safety of either infliximab or adalimumab in 362 patients with anti-TNF-α naïve Crohn's disease  Academic Article
• The incidence of inflammatory bowel disease in the pediatric population of Southwestern Ontario  Academic Article
• The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13  Academic Article
• The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations  Academic Article
• Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements  Academic Article
• Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease  Academic Article
• Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC  Academic Article